FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...
"This is a 35 year old male with past medical history of asthma, atopic dermatitis, allergic rhinitis, gastroesophageal reflux, and food allergies presenting with severe asthma, not well controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results